Comparison of Acute Physiology and Chronic Health Evaluation (APACHE II) and Simplified Acute Physiology Score (SAPS II) in a Greek general intensive care unit

por Gkolfinopoulou, K, Kouvatseas, G, Armaganidis, A, Dafni, U
Publicado 2005

“The first ones now, will later be last”: understanding the importance of historical context when reading ESMO-MCBS scores

por Cherny, N.I., Dafni, U., Pentheroudakis, G., Piccart, M., Zygoura, P., Gyawali, B., de Vries, E.G.E.
Publicado 2022

Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period

por Lazor-Blanchet, C., Zygoura, P., Dafni, U., Lamoth, F., Tsourti, Z., Lobritz, M.A., Regina, J., Grandbastien, B., Fenwick, C., Pantaleo, G., Calandra, T., Meylan, S.
Publicado 2022

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers

por Cherny, N I, Sullivan, R, Dafni, U, Kerst, J M, Sobrero, A, Zielinski, C, Piccart, M J, Bogaerts, J, Tabernero, J, Latino, N J, de Vries, E G E
Publicado 2016

Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines

por Zarkavelis, G., Amylidi, A.L., Verbaanderd, C., Cherny, N.I., Metaxas, Y., de Vries, E.G.E., Zygoura, P., Amaral, T., Jordan, K., Strijbos, M., Dafni, U., Latino, N., Galotti, M., Lordick, F., Giuliani, R., Pignatti, F., Pentheroudakis, G.
Publicado 2022

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

por Koutras, A K, Kalogeras, K T, Dimopoulos, M-A, Wirtz, R M, Dafni, U, Briasoulis, E, Pectasides, D, Gogas, H, Christodoulou, C, Aravantinos, G, Zografos, G, Timotheadou, E, Papakostas, P, Linardou, H, Razis, E, Economopoulos, T, Kalofonos, H P, Fountzilas, G
Publicado 2008

LBA70 COVID-19 in cancer patients: Update from the joint analysis of ESMO-CoCARE, BSMO, PSMO international databases

por Romano, E., Castelo-Branco, L., Tsourti, Z., de Azambuja, E., Gennatas, S., Oliveira, J., Rogado, J., Sekacheva, M., Susnjar, S., Lozano, D. Vinal, Lee, R., Khallaf, S.M., Dimopoulou, G., Pradervand, S., Arnold, D., Harrington, K.J., Michielin, O.A., Dafni, U., Pentheroudakis, G., Peters, S.
Publicado 2022

Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies

por Berghoff, A.S., Sessa, C., Yang, J.C.-H., Tsourti, Z., Tsang, J., Tabernero, J., Peters, S., Linardou, H., Letsch, A., Haanen, J., Garralda, E., Garassino, M.C., Furness, A.J.S., Felip, E., Dimopoulou, G., Dafni, U., Choo, S.P., Banerjee, S., Bajpai, J., Adjei, A.A., Garrido, P.
Publicado 2021

Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC—a systematic review and meta-analysis

por Dafni, U., Soo, R.A., Peters, S., Tsourti, Z., Zygoura, P., Vervita, K., Han, J.-Y., De Castro, J., Coate, L., Früh, M., Hashemi, S.M.S., Nadal, E., Carcereny, E., Sala, M.A., Bernabé, R., Provencio, M., Cuffe, S., Roschitzki-Voser, H., Ruepp, B., Rosell, R., Stahel, R.A.
Publicado 2022

237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries

por Cortellini, A., Dettorre, G., Dafni, U., Aguilar Company, J., Castelo-Branco, L., Lambertini, M., Gennatas, S., Rogado, J., Vinal Lozano, D., Harrington, K.J., Tsourti, Z., Michielin, O.A., Pommeret, F., Brunet Vidal, J.M., Tabernero, J., Pentheroudakis, G., Gennari, A., Peters, S., Romano, E., Pinato, D.J.
Publicado 2022

COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

por Martin, P., Tsourti, Z., Ribeiro, J., Castelo-Branco, L., de Azambuja, E., Gennatas, S., Rogado, J., Sekacheva, M., Šušnjar, S., Viñal, D., Lee, R., Khallaf, S., Dimopoulou, G., Pradervand, S., Whisenant, J., Choueiri, T.K., Arnold, D., Harrington, K., Punie, K., Oliveira, J., Michielin, O., Dafni, U., Peters, S., Pentheroudakis, G., Romano, E.
Publicado 2023

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

por Gyawali, B., de Vries, E.G.E., Dafni, U., Amaral, T., Barriuso, J., Bogaerts, J., Calles, A., Curigliano, G., Gomez-Roca, C., Kiesewetter, B., Oosting, S., Passaro, A., Pentheroudakis, G., Piccart, M., Roitberg, F., Tabernero, J., Tarazona, N., Trapani, D., Wester, R., Zarkavelis, G., Zielinski, C., Zygoura, P., Cherny, N.I.
Publicado 2021

COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)

por Castelo-Branco, L., Tsourti, Z., Gennatas, S., Rogado, J., Sekacheva, M., Viñal, D., Lee, R., Croitoru, A., Vitorino, M., Khallaf, S., Šušnjar, S., Soewoto, W., Cardeña, A., Djerouni, M., Rossi, M., Alonso-Gordoa, T., Ngelangel, C., Whisenant, J.G., Choueiri, T.K., Dimopoulou, G., Pradervand, S., Arnold, D., Harrington, K., Michielin, O., Dafni, U., Pentheroudakis, G., Peters, S., Romano, E.
Publicado 2022